Thor Medical ASA
NANOV | OL
Overview
Corporate Details
- ISIN(s):
- NO0010597883 (+1 more)
- LEI:
- 5967007LIEEXZXG6DK30
- Country:
- Norway
- Address:
- Drammensveien 167, 0277 Oslo
- Website:
- https://www.thormedical.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
From rock to cancer drugs - Thor Medical is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The production process is based on a novel technology developed by Thor Medical that combines high efficiency and competitive cost structure with best in class environmental friendliness. All chemicals and radioactive materials are reprocessed and reused; therefore, the process produces very little waste. The process extracts only the radioactivity naturally occurring in thorium and therefore it requires no irradiation in nuclear reactors or high-cost accelerators. Since the source is thorium which decays with a half-life of 14 billion years we can produce continuously and provide a reliable supply of the sought-after alpha-particle emitters.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-04 07:30 |
Regulatory News Service
Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228 - …
|
English | 64.1 KB | |
| 2025-08-04 07:30 |
Regulatory News Service
Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228
|
English | 7.7 KB | |
| 2025-08-01 08:58 |
Declaration of Voting Results & Voting Rights Announcements
Thor Medical ASA - Share capital increase in relation to Subsequent Offering is…
|
English | 46.1 KB | |
| 2025-08-01 08:58 |
Declaration of Voting Results & Voting Rights Announcements
Thor Medical ASA - Share capital increase in relation to Subsequent Offering is…
|
English | 2.0 KB | |
| 2025-07-04 10:41 |
Regulatory News Service
Thor Medical ASA: Final results of the Subsequent Offering - Attachment: Downlo…
|
Norwegian | 59.1 KB | |
| 2025-07-04 10:41 |
Regulatory News Service
Thor Medical ASA: Final results of the Subsequent Offering
|
Norwegian | 10.1 KB | |
| 2025-07-03 07:00 |
Regulatory News Service
Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16…
|
Norwegian | 62.0 KB | |
| 2025-07-03 07:00 |
Regulatory News Service
Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16…
|
English | 10.1 KB | |
| 2025-06-26 14:33 |
Directors' Dealings
Thor Medical ASA: Primary insider notification and disclosure of large sharehol…
|
English | 120.0 KB | |
| 2025-06-26 14:33 |
Major Shareholding Notification
Thor Medical ASA: Primary insider notification and disclosure of large sharehol…
|
English | 51.7 KB | |
| 2025-06-26 14:33 |
Major Shareholding Notification
Thor Medical ASA: Primary insider notification and disclosure of large sharehol…
|
English | 3.9 KB | |
| 2025-06-26 14:24 |
Declaration of Voting Results & Voting Rights Announcements
Thor Medical ASA - Share capital increase in relation to the Private Placement …
|
English | 48.3 KB | |
| 2025-06-26 14:24 |
Share Issue/Capital Change
Thor Medical ASA - Share capital increase in relation to the Private Placement …
|
English | 2.3 KB | |
| 2025-06-26 07:00 |
Prospectus
Thor Medical ASA: Commencement of the subscription period for the subsequent of…
|
English | 65.0 KB | |
| 2025-06-26 07:00 |
Prospectus
Thor Medical ASA: Commencement of the subscription period for the subsequent of…
|
English | 11.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| Incanthera plc | United Kingdom | N/A | ||
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH | |
|
IntegraGen | France | ALINT | |
|
INTERNATIONAL BIOTECHNOLOGY TST PLC | United Kingdom | IBT | |
|
Inventiva | France | IVA | |
|
IRLAB Therapeutics | Sweden | IRLAB | |
|
Isofol Medical | Sweden | ISOFOL | |
|
Jonix | Italy | JNXI | |
|
Kadimastem Ltd. | Israel | KDST |